Zurich Cantonal Bank’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,582
| Closed | -$38.6K | – | 2677 |
|
|
2024
Q2 | $38.6K | Hold |
4,582
| – | – | ﹤0.01% | 2566 |
|
|
2024
Q1 | $66.2K | Sell |
4,582
-5,388
| -54% | -$89.1K | ﹤0.01% | 2515 |
|
|
2023
Q4 | $215K | Hold |
9,970
| – | – | ﹤0.01% | 2039 |
|
|
2023
Q3 | $192K | Buy |
9,970
+4,547
| +84% | +$97K | ﹤0.01% | 1996 |
|
|
2023
Q2 | $138K | Hold |
5,423
| – | – | ﹤0.01% | 2159 |
|
|
2023
Q1 | $196K | Hold |
5,423
| – | – | ﹤0.01% | 1872 |
|
|
2022
Q4 | $215K | Buy |
5,423
+900
| +20% | +$37.4K | ﹤0.01% | 1778 |
|
|
2022
Q3 | $211K | Hold |
4,523
| – | – | ﹤0.01% | 1725 |
|
|
2022
Q2 | $198K | Sell |
4,523
-38
| -0.8% | -$2.09K | ﹤0.01% | 1797 |
|
|
2022
Q1 | $330K | Hold |
4,561
| – | – | ﹤0.01% | 1604 |
|
|
2021
Q4 | $370K | Buy |
4,561
+1,206
| +36% | +$121K | ﹤0.01% | 1673 |
|
|
2021
Q3 | $390K | Hold |
3,355
| – | – | ﹤0.01% | 1463 |
|
|
2021
Q2 | $556K | Hold |
3,355
| – | – | ﹤0.01% | 1173 |
|
|
2021
Q1 | $468K | Sell |
3,355
-456
| -12% | -$74.4K | ﹤0.01% | 1270 |
|
|
2020
Q4 | $660K | Hold |
3,811
| – | – | ﹤0.01% | 1129 |
|
|
2020
Q3 | $531K | Buy |
3,811
+579
| +18% | +$77.4K | ﹤0.01% | 1069 |
|
|
2020
Q2 | $386K | Buy |
3,232
+894
| +38% | +$106K | ﹤0.01% | 1137 |
|
|
2020
Q1 | $234K | Buy |
2,338
+143
| +7% | +$17.2K | ﹤0.01% | 1144 |
|
|
2019
Q4 | $258K | Buy |
2,195
+413
| +23% | +$40.9K | ﹤0.01% | 1197 |
|
|
2019
Q3 | $153K | Hold |
1,782
| – | – | ﹤0.01% | 1385 |
|
|
2019
Q2 | $116K | Hold |
1,782
| – | – | ﹤0.01% | 1534 |
|
|
2019
Q1 | $111K | Hold |
1,782
| – | – | ﹤0.01% | 1519 |
|
|
2018
Q4 | $69K | Hold |
1,782
| – | – | ﹤0.01% | 1837 |
|
|
2018
Q3 | $102K | Hold |
1,782
| – | – | ﹤0.01% | 1695 |
|
|
2018
Q2 | $142K | Buy |
1,782
+455
| +34% | +$37.7K | ﹤0.01% | 1458 |
|
|
2018
Q1 | $115K | Hold |
1,327
| – | – | ﹤0.01% | 1521 |
|
|
2017
Q4 | $92K | Buy |
1,327
+268
| +25% | +$21.4K | ﹤0.01% | 1619 |
|
|
2017
Q3 | $96K | Hold |
1,059
| – | – | ﹤0.01% | 1432 |
|
|
2017
Q2 | $79K | Buy |
1,059
+113
| +12% | +$9.05K | ﹤0.01% | 1504 |
|
|
2017
Q1 | $89K | Hold |
946
| – | – | ﹤0.01% | 1439 |
|
|
2016
Q4 | $69K | Sell |
946
-295
| -24% | -$25.3K | ﹤0.01% | 1518 |
|
|
2016
Q3 | $130K | Buy |
1,241
+82
| +7% | +$7.41K | ﹤0.01% | 1107 |
|
|
2016
Q2 | $85K | Buy |
1,159
+772
| +199% | +$52.4K | ﹤0.01% | 1234 |
|
|
2016
Q1 | $22K | Hold |
387
| – | – | ﹤0.01% | 1980 |
|
|
2015
Q4 | $26K | Buy |
387
+209
| +117% | +$11.2K | ﹤0.01% | 1868 |
|
|
2015
Q3 | $8K | Buy |
+178
| New | +$8.63K | ﹤0.01% | 2239 |
|
Other funds holding NVRO
ACH
AC
EC
B
RSCM
Zurich Cantonal Bank's NVRO Position: Q3 2024 in Review
Zurich Cantonal Bank sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 4,582 shares — an estimated $38.6K sold.
Zurich Cantonal Bank first reported a position in NVRO in Q3 2015 and held it in 36 quarters. The position peaked at $660K in Q4 2020. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.
- Zurich Cantonal Bank reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
- Zurich Cantonal Bank sold 4,582 NEVRO CORP. shares in Q3 2024, an estimated $38.6K.
- Zurich Cantonal Bank first reported a position in NEVRO CORP. in Q3 2015 and held it in 36 quarters.
- Zurich Cantonal Bank's NEVRO CORP. position peaked at $660K in Q4 2020.
- 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.
Based on Zurich Cantonal Bank's 13F filing for Q3 2024, filed 8 Nov 2024.